CRA was retained by the Plaintiff in a trade secrets litigation. CRA’s expert evaluated possible settlement options related to an alleged theft of trade secrets. The team calculated the expected present value (EPV) for the upfront and development milestones of the asset. The EPV model was used to aid counsel in settlement discussions.
MFN is rewriting the launch planning playbook: Commercial and market access strategies must integrate to succeed
MFN-related uncertainty is reshaping pharmaceutical launch planning by making pricing, sequencing, and forecasting decisions more interconnected and...